Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues – Cyclic peptides
Reexamination Certificate
2005-06-28
2005-06-28
Weber, Jon (Department: 1653)
Chemistry: natural resins or derivatives; peptides or proteins;
Peptides of 3 to 100 amino acid residues
Cyclic peptides
C530S327000, C514S011400, C514S014800
Reexamination Certificate
active
06911525
ABSTRACT:
The present invention relates to novel lipopeptide compounds. The invention also relates to pharmaceutical compositions of these compounds and methods of using these compounds as antibacterial compounds. The invention also relates to methods of producing these novel lipopeptide compounds and intermediates used in producing these compounds.
REFERENCES:
patent: 4396543 (1983-08-01), Debono
patent: 4399067 (1983-08-01), Debono
patent: 4482487 (1984-11-01), Abbott et al.
patent: 4524135 (1985-06-01), Abbott et al.
patent: 4537717 (1985-08-01), Abbott et al.
patent: RE32310 (1986-12-01), Debono
patent: RE32311 (1986-12-01), Debono
patent: 5573936 (1996-11-01), Kreuzman et al.
patent: 5629288 (1997-05-01), Lattrell et al.
patent: 5912226 (1999-06-01), Baker et al.
patent: 095 295 (1983-11-01), None
patent: 178 152 (1986-04-01), None
patent: 0 885 957 (1998-12-01), None
patent: WO 99/43700 (1999-09-01), None
Tally, F.P. et al., “Daptomycin: a Novel Agent for Gram-positive Infections,”Exp. Opin. Invest. Drugs8: 1223-1238 (1999).
Alborn, W. E. Jr. et al., “Daptomycin Disrupts Membrane Potential in GrowingStaphylococcus aureus,” Antimicrobial Agents and Chemotherapy35: 2282-2287 (1991).
Allen, N. E. et al. “Inhibition of Peptidoglycan Biosynthesis in Gram-Positive Bacteria by LY146032,”Antimicrobial Agents and Chemotherapy31: 1093-1099 (1987).
Allen, N. E. et al. “Inhibition of Membrane Potential-Dependent Amino Acid Transport by Daptomycin,”Antimicrobial Agents and Chemotherapy35: 2639-2642 (1991).
Baltz, R. H., “Lipopeptide Antibiotics Produced byStreptomyces roseosporusandStreptomyces fradiae,” inBiotechnology of Antibiotics, 2d Ed., 415-435 (1997).
Bingen, E. et al. “Bactericidal Activity of Daptomycin Against Vancomycin-ResistantEnterococcus faeciumin an in Vitro Pharmacokinetic Model,”Eur. J. Clin. Microbiol. Infect. Dis. 10: 1062-1065 (1991).
Boeck, LaVerne D. et al. “Deacylation of A21978C, An Acidic Lipopeptide Antibiotic Complex, byActinoplanes utahensis,” Journal of AntibioticsXLI: 1085-1092 (1988).
Boeck, L. D. et al. “A54145, A New Lipopeptide Antibiotic Complex: Discovery, Taxonomy, Fermentation and HPLC,”Journal of AntibioticsXLIII: 587-593 (1990).
Champlin, Franklin R. et al. “Cell Envelope Impermeability to Daptomycin inPseudomonas aeruginosaandPasteurella multocida,” Current Microbiology21: 367-372 (1990).
Chong, Pei Pei et al. “Physical Identification of a Chromosomal Locus Encoding Biosynthetic Genes for the Lipopeptide Calcium-Dependent Antibiotic (CDA) ofStreptomyces coelicolorA3(2),”Microbiology144: 193-199 (1998).
Debono, M. et al. “A21978C, A Complex of New Acidic Peptide Antibiotics: Isolation, Chemistry, and Mass Spectral Structure Elucidation,”Journal of AntibioticsXL: 761-777 (1987).
Debono, M. et al. “Enzymatic and Chemical Modifications of Lipopeptide Antibiotic A21978C: The Synthesis and Evaluation of Daptomycin (LY146032),”Journal of AntibioticsXLI: 1093-1105 (1988).
Debono, M. et al. “Synthesis of New Analogs of Echinocandin B by Enzymatic Deacylation and Chemical Reacylation of the Echinocandin B Peptide: Synthesis of the Antifungal Agent Cilofungin (LY121019),”Journal of AntibioticsXLII: 389-397 (1989).
Dong, Mei-Yan et al. “Treatment ofClostridium difficileColitis in Hamsters with a Lipopeptide Antibiotic, LY146032,”Antimicrobial Agents and Chemotherapy31: 1135-1136 (1987).
Eid, Pascale et al. “Effect of Daptomycin on the Barotropic Behavior of Dioleoylphosphatidylglycerol: An Infrared Spectroscopic Investigation,”Chemistry and Physics of Lipids83: 131-140 (1996).
Eliopoulos, George M. et al. “In Vitro Activity and Mechanism of Action of A21978C1, a Novel Cyclic Lipopeptide Antibiotic,”Antimicrobial Agents and Chemotherapy27: 357-362 (1985).
Huber, F. M. et al. “The Formation of Daptomycin by Supplying Decanoic Acid toStreptomyces roseosporusCultures Producing the Antibiotic Complex A21978C,”Journal of Biotechnology7: 283-292 (1988).
Huber, F. M. et al. “The Synthesis of A21978C Analogs byStreptomyces roseosporusCultivated Under Carbon Limitation and Fed Fatty Acids,”Biotechnology Letters12: 789-792 (1990).
Inokoshi, Junji et al. “Cloning and Sequencing of the Aculeacin A Acylase-Encoding Gene FromActinoplanes utahensisand Expression inStreptomyces lividans,” Gene119: 29-35 (1992).
Inokoshi, Junji et al. “Efficient Production of Aculeacin A Acylase in RecombinantStreptomycesstrains,”Appl. Microbiol. Biotechnol. 39: 532-536 (1993).
Kempter, Christoph et al. “CDA: Calcium-Dependent Peptide Antibiotics fromStreptomyces coelicolorA3(2) Containing Unusual Residues,”Agnew. Chem. Int. Ed. Engl. 36: 498-501 (1997).
Kirsch, Lee E. et al. “Kinetics of the Aspartyl Transpeptidation of Daptomycin, a Novel Lipopeptide Antibiotic,”Pharmaceutical Research6: 387-393 (1989).
Lakey, Jeremy H. et al. “The Role of Acyl Chain Character and Other Determinants on the Bilayer Activity of A21978C An Acidic Lipopeptide Antibiotic,”Biochimica et Biophysica Acta859: 219-226 (1986).
Lakey, Jeremy H. et al. “Fluorescence Indicates a Calcium-Dependent Interaction Between the Lipopeptide Antibiotic LY146032 and Phospholipid Membranes,”Biochemistry27: 4639-4645 (1988).
Lakey, Jeremy H. et al. “The Lipopeptide Antibiotic A21978C Has a Specific Interaction With DMPC Only in the Presence of Calcium Ions,”Biochimica et Biophysica Acta985: 60-66 (1989).
Lee, Belle L. et al. “Effect of Protein Binding of Daptomycin on MIC and Antibacterial Activity,”Antimicrobial Agents and Chemotherapy35: 2505-2508 (1991).
Liebowitz, Lynne D. et al. “In Vitro Selection of Bacteria Resistant to LY146032, a New Cyclic Lipopeptide,”Antimicrobial Agents and Chemotherapy32: 24-26 (1988).
Maget-Dana, Régine et al. “A Comparative Monomolecular Film Study of Antibiotic A21978C Homologues of Various Lipid Chain Length,”Biochimica et Biophysica Acta962: 201-207 (1988).
Zambias, Robert A. et al. “Preparation and Structure-Activity Relationships of Simplified Analogues of the Antifungal Agent Cilofungin: A Total Synthesis Approach,”Journal of Medicinal Chemistry35: 2843-2855 (1992).
Zmijewski, M.J. et al. “Role of Branched Chain Fatty Acid Precursors in Regulating Factor Profile in the Biosynthesis of A21978 C Complex,”Journal of AntibioticsXXXIX: 1483-1485 (1986).
Christensen Dale
Finn John
Hill Jason
Keith Dennis
Lazarova Tsvetelina
Cubist Pharmaceuticals, Inc.
Douros Timothy J.
Lukton David
Mandelblatt Jill M.N.
Weber Jon
LandOfFree
Lipopeptides as antibacterial agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Lipopeptides as antibacterial agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Lipopeptides as antibacterial agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3501489